Experienced Leadership

Helix is led by experienced Management and Board team with excellent pharmaceutical development expertise and proven business skills. The group is committed in developing novel medicines through DOS47 and cell-based platforms.

MANAGEMENT BOARD

Heman Chao

CEO
PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.

Frank Michalargias

CFO
CPA, CA

Public company CFO with broad industry experience including senior positions with Unilever and Huhtamaki Oy

Paweł Wiśniewski

CEO Poland
PhD

Biochemistry background;  co-founder Institute of Genetic Analysis

BOARD OF DIRECTORS

Sławomir Majewski

MD, PhD

Vice Rector of the Medical University of Warsaw, Corresponding Member of the Polish Academy of Science

Marek Orłowski

MD

Chairman/Founder Adiuvo Investments, Founder Nepentes, sold to Sanofi Aventis

Sylwester Cacek

Founder of Dominet Bank which was sold to Fortis Bank Group; President/founder of Sfinks Polska

Heman Chao

PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.

Scientific and Strategic Advisory Board (SSAB)

Daniel Von Hoff

Dr. Von Hoff is currently Physician in Chief, Distinguished Professor Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Senior Consultant, Clinical Investigations for the City of Hope; Chief Scientific Officer for HonorHealth Research Institute; Medical Director of Research, Chief Scientific Officer, US Oncology, Professor of Medicine, Mayo Clinic and past President of the American Association for Cancer Research. Dr. Von Hoff was involved in a development of a number of therapeutics that are routinely used in treating cancer today.

Kazimierz Roszkowski-Sliz

Dr. Roszkowski-Sliz is the Director and Head of Clinical of the National Tuberculosis and Lung Diseases Research Institute in Poland; National Consultant for Lung Diseases, Ministry of Health; Chairman of Scientific Council of Ministry of Health; and Chairman of the Scientific Council of the National Center Institute of Oncology Poland. Dr. Roszkowski-Sliz is an expert in the treatment of lung diseases.

Robert Gillies

Dr. Robert Gillies holds the Martin Silbiger Endowed Chair and is Chair of the Department of Cancer Physiology and Vice-Chair (Research) of the Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute; and Professor Emeritus, Departments of Radiology and Biomedical Engineering, College of Medicine University of Arizona. He is past president of the Society for Molecular Imaging and has served on numerous grant review panels for the NIH and the DoD, consulting on cancer physiology and imaging. Dr. Gillies is an expert in tumor acidity and has published extensively in this area of research.

Heman Chao

PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.